In this episode I chat with Sam Banister, the Chief Science Officer at Psylo. Psylo is an Australian biotechnology startup that is developing novel, psychedelic inspired molecules to treat various brain issues.

We discuss all things psychedelics, biotech, drug development, building companies, mental health issues, the new TGA reform to reschedule MDMA and Psilocybin in Australia and much more.